mounjaro vs glp-1 receptor agonists Mounjaro Beats Ozempic, So Why
Description
Quick Answer: Semaglutide maintenance dose every other week is not FDA-approved and represents off-label use that may compromise treatment efficacy and glycemic control
Omeprazole is a proton pump inhibitor that reduces stomach acid production, whilst Wegovy (semaglutide) is a GLP-1 receptor agonist that slows gastric emptying and reduces appetite for weight management
At Skippack Pharmacy, your health is our priority
You dont necessarily need dramatic weight loss to benefit
